🔴 Senti Biosciences is trading 5% down today after broader risk-off trading pressured biotech stocks

Senti Biosciences is trading 5.1% down now at $0.35 after broader risk-off trading pressured biotechnology and growth stocks on September 1, 2026.

• The XBI biotech ETF is down 4.24%, while the S&P 500 and Nasdaq are also lower amid geopolitical tensions, higher oil prices, inflation concerns, and rising bond yields.
• No clear company-specific announcement was identified; the latest major corporate event was the July 15 SENTI-202 transaction.